Fig. 1From: A pilot study of the immunogenicity of a 9-peptide breast cancer vaccine plus poly-ICLC in early stage breast cancerSchema. The general schema of treatment including the timing of the vaccine series and the times for blood draws for ELIspot analysis is shownBack to article page